Norris Medicines reports standalone net loss of Rs 3.17 crore in the March 2021 quarter

Sales rise 88.97% to Rs 2.57 crore

Net Loss of Norris Medicines reported to Rs 3.17 crore in the quarter ended March 2021 as against net loss of Rs 0.55 crore during the previous quarter ended March 2020. Sales rose 88.97% to Rs 2.57 crore in the quarter ended March 2021 as against Rs 1.36 crore during the previous quarter ended March 2020.

For the full year,net loss reported to Rs 4.96 crore in the year ended March 2021 as against net loss of Rs 2.84 crore during the previous year ended March 2020. Sales rose 56.25% to Rs 12.25 crore in the year ended March 2021 as against Rs 7.84 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales2.571.36 89 12.257.84 56 OPM %-40.47-67.65 --14.20-27.55 - PBDT-2.07-1.20 -73 -3.32-2.95 -13 PBT-2.20-1.39 -58 -3.99-3.68 -8 NP-3.17-0.55 -476 -4.96-2.84 -75

Powered by Capital Market - Live News